|
RAD51AP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.84181616811475E-13 |
| Normal-vs-Stage2 |
2.161500E-03 |
| Normal-vs-Stage3 |
2.06999999999846E-05 |
| Normal-vs-Stage4 |
3.777500E-03 |
| Stage1-vs-Stage2 |
4.891800E-01 |
| Stage1-vs-Stage3 |
9.699200E-03 |
| Stage1-vs-Stage4 |
1.324370E-02 |
| Stage2-vs-Stage3 |
9.386300E-02 |
| Stage2-vs-Stage4 |
1.648580E-01 |
| Stage3-vs-Stage4 |
8.821800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.06090000515391E-08 |
| Normal-vs-Asian |
6.387800E-02 |
| Caucasian-vs-AfricanAmerican |
9.258000E-01 |
| Caucasian-vs-Asian |
4.688400E-01 |
| AfricanAmerican-vs-Asian |
4.707200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
3.36990002569593E-09 |
| Male-vs-Female |
1.319640E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.57180000027024E-07 |
| Normal-vs-Extreme_Weight |
1.09390052571712E-10 |
| Normal-vs-Obese |
1.23500000004384E-07 |
| Normal-vs-Extreme_Obese |
3.205800E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.227180E-01 |
| Normal_Weight-vs-Obese |
6.597600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.276000E-03 |
| Extreme_Weight-vs-Obese |
4.589700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.892300E-02 |
| Obese-vs-Extreme_Obese |
1.060080E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.158390E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(61-80Yrs) |
3.21630500010883E-11 |
| Normal-vs-Age(81-100Yrs) |
1.876430E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.716500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.194500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.070160E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.270200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.273600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.508600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.81600000037641E-07 |
| Normal-VS-KIRP CIMP |
2.379500E-03 |
| Normal-VS-Unclassified PRCC |
3.16209999962069E-07 |
| Type1 PRCC-VS-Type2 PRCC |
5.569000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.032110E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.086200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.333980E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.440840E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.727500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.494600000429E-07 |
| Normal-vs-N1 |
1.94540999999271E-05 |
| Normal-vs-N2 |
1.776040E-01 |
| N0-vs-N1 |
1.276020E-03 |
| N0-vs-N2 |
3.851600E-01 |
| N1-vs-N2 |
5.828400E-01 |
|
|
